Bacil Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consider and approve 1. Unaudited Financial Results ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bacil Pharma Ltd has informed BSE that its Board of Directors will meet on Thursday, 13th November 2025. The main agenda is to consider and approve the Unaudited Financial Results for the half-year and quarter ended 30th September 2025. Any other business may be taken up with the Chairperson's permission. This is a routine regulatory disclosure under SEBI Listing Regulations, giving advance notice of an upcoming results announcement.
Investors should watch for the unaudited Q2/H1 FY26 results expected to be released after the board meeting on 13th November 2025. No immediate impact on the stock price from this notice itself, as it is a standard procedural filing.